The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Registry Platform Colorectal Cancer
Official Title: Clinical Research Platform for Molecular Testing, Treatment, Quality of Life and Outcome of Patients With Metastatic Colorectal Cancer Receiving Systemic Therapy (AZURITE)
Study ID: NCT04867525
Brief Summary: The registry aims to collect and analyse information on the antineoplastic treatment of patients with metastatic colorectal cancer, treated in palliative intention in daily routine practice in Germany.
Detailed Description: AZURITE is a national, observational, prospective, longitudinal, multicenter cohort study (tumor registry platform) with the purpose to record information on the antineoplastic treatment of metastatic colorectal cancer in Germany. The registry will follow patients for up to three years. It will identify common therapeutic sequences and changes in the treatment of the disease. At inclusion, data in patient characteristics, comorbidities, tumor characteristics and previous treatments are collected. During the course of observation data on all systemic treatments, radiotherapies, surgeries, and outcome are documented. Health-related quality of life (HRQoL) will be evaluated for up to three years.
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Multiple sites all over germany, Multiple Locations, , Germany
Name: Nicolas Graf, PD Dr.
Affiliation: Deggendorf
Role: STUDY_CHAIR
Name: Frank Kullmann, Prof. Dr.
Affiliation: Weiden i.d.O.
Role: STUDY_CHAIR
Name: Marlies Michl, PD Dr.
Affiliation: München
Role: STUDY_CHAIR
Name: Jens Neumann, Prof. Dr.
Affiliation: München
Role: STUDY_CHAIR
Name: Roland Schnell, PD Dr.
Affiliation: Frechen
Role: STUDY_CHAIR
Name: Sebastian Stintzing, Prof. Dr.
Affiliation: Berlin
Role: STUDY_CHAIR
Name: Karin Potthoff, Dr.
Affiliation: Freiburg i. Br.
Role: STUDY_CHAIR